Tecentriq 1 200 mg concentrate for solution for infusion, CISPLATIN , CARBOPLATIN , BNT327, ETOPOSIDE
BNT327-03
Phase 3 small_molecule active
Quick answer
Tecentriq 1 200 mg concentrate for solution for infusion, CISPLATIN , CARBOPLATIN , BNT327, ETOPOSIDE for English First-line extensive-stage small-cell lung cancer (ES-SCLC) is a Phase 3 program (small_molecule) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- English First-line extensive-stage small-cell lung cancer (ES-SCLC)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active